Sun Pharma Advanced Research Company Ltd
SPARC price chart
Daily close · 5-year history
Instrument details
Identifiers & classification
- Symbol
- SPARC
- MB Code
- MBEQU3419
- ISIN
- INE232I01014
- BSE code
- 532872
- Industry group
- Pharmaceuticals & Biotechnology
- Screener
- View peers →
Latest earnings
Most recent declared quarter
- Quarter
- Mar 2026
- Revenue
- 1853.22 Cr
- Net profit
- 1761.34 Cr
- EPS
- 54.27
- YoY revenue
- +6715.81%
Company documents
12 PDFs across 4 categories
Audited annual reports & financial statements
Earnings call transcripts & Q&A
Investor decks & strategy updates
Exchange filings & corporate announcements
Corporate timeline
Earnings, news & corporate actions for SPARC
On February 1, 2026, Sun Pharma shares rose nearly 4% after the company reported a 16% increase in consolidated net profit for Q3 ending …
Sun Pharma shares rose nearly 1% following a 16% increase in net profit for Q3 ended December 31, 2025, reaching Rs 3,369 crore. Total re…
Sun Pharma has made a non-binding offer to acquire US-based Organon, marking its largest global acquisition attempt. The company has secu…
Motilal Oswal maintains a 'Buy' rating on Sun Pharma, expecting a 14% earnings CAGR from FY25-27E, driven by a 17% sales CAGR in specialt…
Sun Pharma's Q1 net profit fell 19.6% YoY to Rs 2,278.6 crore, despite a 9.5% increase in revenue from operations. The decline in profit …
Sun Pharma reported a 20% decline in net profit for Q1, totaling Rs 2,278.6 crore, down from Rs 2,835.6 crore in the same quarter last year.
Stocks to watch on July 25 include Sun Pharma, eClerx, IEX, Anant Raj, REC, Aether Industries, L&T, Enviro Infra, GR Infraprojects, and A…
Sun Pharma has launched Leqselvi in the US for alopecia areata following a patent settlement with Incyte Corp, involving an upfront fee a…
Price returns
Historical performance
Technicals
Indicator consensus